abrdn Life Sciences Investors: Form SCHEDULE 13D/A, filed Apr 1, 2025
Filed with the SEC on Apr 1, 2025 and accepted by EDGAR at Apr 2, 2025, 01:49 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001062993-25-006767. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.